Cargando…
Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome
BACKGROUND: Treatment options for patients with COVID-19-related acute respiratory distress syndrome (ARDS) are desperately needed. Allogeneic human umbilical cord derived mesenchymal stromal cells (hCT-MSCs) have potential therapeutic benefits in these critically ill patients, but feasibility and s...
Autores principales: | Shaz, Beth H, Kraft, Bryan D, Troy, Jesse D, Poehlein, Emily, Chen, Lingye, Cheatham, Lynn, Manyara, Raha, Hanafy, Khalid, Brown, Linda, Scott, Margaret, Palumbo, Ralph, Vrionis, Frank, Kurtzberg, Joanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108718/ https://www.ncbi.nlm.nih.gov/pubmed/36929827 http://dx.doi.org/10.1093/stcltm/szad009 |
Ejemplares similares
-
Abstract 12 Phase I Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19–Related Acute Respiratory Distress Syndrome
por: Kraft, Bryan, et al.
Publicado: (2022) -
Mesenchymal Stem/Stromal Cells: SAFETY OF CORD TISSUE DERIVED MESENCHYMAL STROMAL CELLS IN COVID-19 RELATED ACUTE RESPIRATORY DISTRESS SYNDROME
por: Shaz, B., et al.
Publicado: (2022) -
Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder
por: Sun, Jessica M., et al.
Publicado: (2020) -
Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank
por: Guggenheim, Dana S, et al.
Publicado: (2022) -
The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder
por: Borre, Ethan D., et al.
Publicado: (2023)